Aptorum Group Limited (NASDAQ:APM – Get Free Report) was the recipient of a significant drop in short interest in September. As of September 15th, there was short interest totalling 4,200 shares, a drop of 30.0% from the August 31st total of 6,000 shares. Based on an average trading volume of 13,700 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.2% of the company’s stock are short sold.
Hedge Funds Weigh In On Aptorum Group
An institutional investor recently bought a new position in Aptorum Group stock. Murchinson Ltd. purchased a new position in shares of Aptorum Group Limited (NASDAQ:APM – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 14,000 shares of the company’s stock, valued at approximately $133,000. Murchinson Ltd. owned about 0.27% of Aptorum Group at the end of the most recent reporting period. 3.80% of the stock is currently owned by institutional investors.
Aptorum Group Stock Down 1.3 %
Aptorum Group stock traded down $0.03 during trading on Friday, reaching $1.85. The stock had a trading volume of 11,613 shares, compared to its average volume of 830,709. Aptorum Group has a 52-week low of $1.35 and a 52-week high of $17.49. The business has a 50 day moving average price of $2.95 and a 200 day moving average price of $4.76. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.20.
About Aptorum Group
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.
Featured Stories
- Five stocks we like better than Aptorum Group
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- Bank Stocks – Best Bank Stocks to Invest In
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
- What Investors Need to Know About Upcoming IPOs
- What Intuitive Machines’ Big NASA Contract Means for Investors
Receive News & Ratings for Aptorum Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptorum Group and related companies with MarketBeat.com's FREE daily email newsletter.
